Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone
- 1 December 1982
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 144 (8), 895-898
- https://doi.org/10.1016/0002-9378(82)90180-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Danazol in the Treatment of EndometriosisDrugs, 1980
- Classification of EndometriosisFertility and Sterility, 1979
- Endocrine Properties and Clinical Application of DanazolFertility and Sterility, 1979
- Antigonadotropin (danazol) in the treatment of endometriosisAmerican Journal of Obstetrics and Gynecology, 1978
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosisAmerican Journal of Obstetrics and Gynecology, 1975
- Contraceptive effectiveness of silastic: Implants containing the progestin R-2323Contraception, 1975
- A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323)Contraception, 1974
- Clinical evaluation of an oral progestin contraceptive, R-2323, 5mg, administered at weekly intervalsContraception, 1974
- Successful inhibition of spermatogenesis in man without loss of libido: A potential new approach to male contraceptionContraception, 1973
- The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian HormonesFertility and Sterility, 1959